US 10940160
Biomarkers for predicting responsiveness to decitabine therapy
granted A61KA61K31/7068
Quick answer
US patent 10940160 (Biomarkers for predicting responsiveness to decitabine therapy) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/7068